Rizzo, Manfredi; Christ, Emanuel R; Rini, Giovam Battista; Spinas, Giatgen A; Berneis, Kaspar (2008). The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance? Expert opinion on pharmacotherapy, 9(13), pp. 2295-303. London: Informa Healthcare 10.1517/14656560802321903
Full text not available from this repository. (Request a copy)Diabetic dyslipidemia is typically characterized by an increase in plasma triglycerides, a decrease in high-density lipoprotein cholesterol and a concomitant increase in atherogenic small dense low-density lipoproteins. Thiazolidindiones are able to lower the levels of fasting glucose and glycated hemoglobin significantly by improving insulin sensitivity, as well as improving some aspects of diabetic dyslipidemia: total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol tend to increase while triglycerides are generally decreased.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition |
UniBE Contributor: |
Christ, Emanuel |
ISSN: |
1465-6566 |
ISBN: |
18710354 |
Publisher: |
Informa Healthcare |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 15:06 |
Last Modified: |
05 Dec 2022 14:20 |
Publisher DOI: |
10.1517/14656560802321903 |
PubMed ID: |
18710354 |
Web of Science ID: |
000259105400008 |
URI: |
https://boris.unibe.ch/id/eprint/28560 (FactScience: 121530) |
Actions (login required)
 |
Edit item |